![Placeholder Image Placeholder Image](https://prod1.novartis.com/us-en/sites/novartis_us/files/placeholder.jpeg)
Tags Archive Navigation
icon
-
Media ReleaseNovartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA-positive metastatic castration-resistant prostate cancer
-
Media ReleaseFDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
-
StorySourcing innovation, strategically
Pagination
- ‹ Previous page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- › Next page